If we had to sum up the start of the 2026 season in one word, it would be conversations! Not the ones that offer reassurance, but the ones that put slides to the test of reality, bring investors and entrepreneurs face to face, and bridge worlds that don’t speak the same language.
It’s also the start of a new chapter under a new identity: LallianSe, Catalyst for Action(s). Every conversation we’ve been part of over the past two months illustrates this mission: LallianSe creates the conditions for the right conversation to happen, at the right time, between the right people.
#MoneyQuest season episode #1 : ERROR 404 When the equity story doesn’t go as planned !
To kick off this second season, we went where things get a little less comfortable… On September 28, Julie Rachline, CEO of LallianSe and former CEO of BrainTale, shared her experience with Eric Garnier, President of Angels Santé, former investor in BrainTale and former member of its board. The discussion explored how an investment thesis evolves when viewed by an investor and a former CEO, what happens when reality forces a pivot, and how to navigate the end of a journey.
Equity Story: ERROR 404! The thesis didn’t work… Failure or experience?
No ready-made answers, just an open space for debate and collective learning.
MoneyQuest Season 2, Episode #2: When the financial roadmap goes off track, can you bounce back?
The conversation continues on October 23. Alongside Jérémy Ballet, CFO and Operating Partner at Alkyon Group, we explored what happens when financial roadmaps go off course: a fundraising round that drags on, an unsuitable capital structure, faster-than-expected growth, or shareholders no longer speaking the same language.
A failed roadmap is rarely an isolated accident. More often, it reveals a deeper misalignment between strategic vision and individual interests. Does it condemn the company to failure, or can it become a turning point?
#Conversations: LallianSe’s conversation starters
Because social media should be a place for interaction and debate, rather than a succession of success stories and top-down certainties, we’re trying something new to open up the conversation with our community.

What really causes a project to fail? Is a good idea enough to make a good project? And what about human capital? Perhaps the right question is no longer “Do we have the talent to innovate?” but rather “Are we truly creating the conditions for innovation?” Are the right people those with the most impressive CVs, or those who also know how to listen and challenge their own assumptions?
These open calls are an invitation to challenge established beliefs and put our own questions and doubts into words. An initiative that builds on LallianSe’s DNA.
Two calls are already live — discover them in our dedicated article here.
Equity story: how do you turn an ambition into a compelling narrative?
Together with Medicen Paris Region and PariSanté Campus, Julie Rachline led a workshop on September 30 as part of a three-session series (September 8, September 30 and October 15) dedicated to fundraising preparation. Alongside ICOSA, Inserm Transfert and DNA Finance, the goal was to bring together the expertise HealthTech founders need, at the right time.
Three key takeaways from the workshop:
Some participants even took on the 1-minute challenge.
Do you speak “LallianSe”? The art of creating a common language
A physician, an entrepreneur, a hospital executive and an investor don’t speak the same language. Yet healthcare innovation can only become reality when they understand one another. This is what we’ve been working on since 2017, drawing on seven years of immersion in the hospital environment at Pitié-Salpêtrière, from the creation of ASIIA to the BrainTale project.
We found the same dynamic at the “From Hospital to Start-up” event at GHU Sorbonne Université, where Julie Rachline moderated a panel featuring four clinicians who are also serial entrepreneurs: Pierre Mozer, Rachel Lévy, Harry Sokol and Louis Puybasset. Our role: translating the challenges of one world into terms another can understand.
#BIG2026 — Can an innovation be excellent… and never get ordered?
On October 8, at the Accor Arena, alongside La French Care and Bpifrance’s Deeptech team, we moderated a panel around a simple question: how can we create solvent demand to accelerate health deeptech? Joining the discussion were Noa Bach (AP-HP, Paris Public Hospital System), Peggy Rematier (Bpifrance), Julie Rachline (LallianSe — Catalyst for Action(s) and former CEO of BrainTale — yes, wearing both hats!), Louis Potel (Resah) and Hicham Chehade (OPTACARE).
The takeaway: between a relevant solution and its first purchase order lie several hurdles — evidence of value, an available budget, a purchasing process, a contractual vehicle and a manufacturer that is still in business and able to invoice. Market access is an integral part of the equity story. It cannot be an afterthought once regulatory approvals have been secured. A major challenge for our healthcare system… and for innovation!
World M&A Alliance: Healthcare in Europe — opportunities for M&A? ?
At the invitation of Inspirit Partners on behalf of the World M&A Alliance, Julie Rachline moderated a discussion bringing together Grégoire Chauvière Le Drian from the European Investment Bank (EIB), Loïc Gonnet, Head of M&A at Sanofi, Benoit Varichon, Partner at ARCHIMED, and Pascal Raidron, Founder of EIGHT ADVISORY.
Their message was clear: a deal must be anticipated and built around people, with a thorough understanding of local dynamics. In healthcare, transactions cannot be considered independently of the ecosystems in which they take place.
Eurasanté x LallianSe: six years of partnership
As partners of BioFIT and MedFIT, we’ve supported these events for six years. They bring together more than 2,000 participants from 35 countries, 200 exhibitors and over 100 international speakers. An ideal setting for us to play our role as a catalyst: building bridges and sparking connections.
Partner benefit: enjoy 20% off your full pass. Get in touch to take advantage of the offer.
World with Women, October 13: When women stop, the world stops (or almost…)
To shine a light on what still goes unseen, the LallianSe team chose to step out of the spotlight for a day. A first step, but not the end of the journey: the real challenge is to contribute collectively, day in and day out. And thanks to Emmanuelle Quilès for bringing us into the loop!
MedTech World Malta 2026: the French delegation is on board
In November, we’re bringing back our French delegation initiative at MedTech World in Malta, taking it a step further and opening up new perspectives. LallianSe is bringing together a French delegation of more than 15 medtech stakeholders — investors and entrepreneurs — for a private session, a workshop on exit strategies and an investor panel.
Among the first participants to join us: Eric Garnier (Angels Santé); Sophie Brac de la Perrière (Healshape); Marielle Mailhes (Bpifrance); Fabrice Paublant (ORIXHA) — and more names to discover.
Our shared goal: create meaningful conversations between investors and CEOs, build bridges across Europe and anticipate exit opportunities. Will you be joining us? It’s a chance to connect in a relaxed, authentic atmosphere!
Enjoy a €150 discount with code MTWM_Lallianse150, and let us know if you’ll be there so we can meet up.
A collective manifesto: the wishes keep coming in
For the past two years, we’ve replaced individual New Year’s wishes with a shared wish box, bringing together contributions to create a collective manifesto. Thank you to Aude Nyadanu (Lowpital and NoviSano), Philippe Mendels-Flandre, AUSTRAL Dx, Karine Lignel, Oncodesign Precision Medicine — OPM and Patrick Errard for contributing. And even outside the New Year’s season — although it’s approaching fast — we’d love to hear your wishes. Share yours here: submit your wish.
In a nutshell, these two months have reinforced our conviction: a good idea is not enough, and neither is a good conversation unless it translates into action(s).
We’ve shed light on failure and pivots without filters, equipped founders with practical tools, translated between worlds, put innovation to the test of market realities and M&A dynamics, and started preparing for what’s next in Malta and beyond.
What comes next? Staying true to our DNA: aligning vision, economic realities and stakeholders, one conversation at a time — or not!
To be continued



Way ahead the term sheet, before the deal, sometimes even before the project is alive.
We’ve spent the last few months opening new conversations : with CEOs, investors, and key stakeholders shaping the future of health innovation in France. We’ve also been wandering how to ignite meaningful conversations between people shaping tomorrow’s healthcare?! Well, its about time to act and not just talk.
This November, we’re heading back to MedTech World in Malta, one step further, and with plural perspectives – this conversation is about to begin… be ready !
Want to join the experience and the conference ? Get €150 off your registration with the code: MTWM_Lallianse150
1 private session for french delegation
1 exit strategy workshop
1 investor panel
1+1+1 = … so much, as it will translate onto 3 exclusive LallianSe highlights, +15 active medtech investors and ambitious, efficient and successful medtech CEOs. For 3 days in Malta.
= 1 shared objective : delivrering value through adequate conversations in health innovation.
We are proud to officially unveil first participants of the #FrenchDelegation embarked by LallianSe – Catalyseur d’action(s) and heading to #MedtechMalta this November :
Eric Garnier, Angels Santé
Marielle Mailhes, Bpifrance
Leila Nicolas Guerlain, GO CAPITAL
Claire Poulard, Turenne Groupe
Sophie Brac de la Perrière, Healshape
Fabrice PAUBLANT, ORIXHA
FranceMedTech #FrenchDelegation #CEO #Investor #MoneyQuest #Investissement


We are thrilled to embark a stellar French #delegation.
And a journey is always about the people you meet along the way :
Eric Garnier, Angels Santé
Sophie Brac de la Perrière, Healshape
Marielle Mailhes, Bpifrance
Fabrice PAUBLANT, ORIXHA
4 seats, 1 destination : creating meaningful #conversations between #investors and #CEOs.
And mostly building bridges across the European #MedTech ecosystem as well as maximizing value and anticipating #exits.
Want to join the #conversation ? Apply for the Exit workshop here : https://shorturl.at/83CeM
The objective? To provide a compass for navigating times of uncertainty, questioning and adaptation. Each episode draws on the experience of the healthcare ecosystem — entrepreneurs, investors and experts — to help navigate the right equation: the right dynamics, with the right people, at the right time.
AI is becoming a part of our daily lives. We explore, we test… but what are the expected—or actual—benefits?
An assistant that saves minutes or even hours. A tool that writes, analyzes, codes, and automates. Tasks disappear, and professions evolve—or vanish entirely. What is the impact on our ecosystem? What can we truly delegate to Claude? How does it affect our work?
Does the failure of a roadmap doom the company? Or can it, on the contrary, become a turning point?
We invite you to join a discussion with Stéphane Milot, CFO & LallianSe expert who will share his (perhaps intense?) relationship with Claude. Together, we will explore how AI can tangibly transform the way we work, while also addressing questions such as:
This will be an open conversation about use cases, experiments, tangible gains, and the limitations of AI. How can AI simplify—or complicate—our tasks, and what are the broader impacts? Let’s open up the discussion and explore this together.
An inspiring and interactive conversation designed for healthcare executives and managers.



Whenever women unite, the world transforms!
On October 13th, with *World with Women*, let’s “disappear” strategically… only to re-emerge stronger and shine a light on what isn’t yet visible enough.
Wearing our LallianSe hats, we chose to disappear – even while in the middle of a meeting.
A single day is a good start, but it’s not enough! What about tomorrow? Let’s all contribute, move forward collectively, and grow together.
#WorldWithWomen #October13 #GenderBalance #GenderEquality #LallianSe
A key paradox emerged from the #conversation we moderated yesterday at #BIG, centered on a simple question: how do we create viable demand to accelerate #deeptech in healthcare?
Because there is a long journey between a relevant, available solution and that first order:
→ a value proposition to build for all stakeholders
→ a healthcare facility that must mobilize time, teams, and a budget to run a pilot
→ a procurement process to understand, anticipate, and coordinate
→ a contractual framework that needs to be in place
→ a manufacturer that is still in business to issue the invoice!
Ultimately, it requires orchestrating #alignment among the decision-maker, the payer, the prescriber, the beneficiary, and the end-user…
Market access is an integral part of the investment narrative (equity story) and cannot be considered only after commercial authorizations are granted. Evidence, the decision-making process, the budget, and the procurement pathway must all be prepared together, as early as possible.
Thanks to Noa Bach (AP-HP, Assistance Publique – Hôpitaux de Paris), Peggy Rematier (Bpifrance), Julie Rachline (LallianSe – Catalyseur d’action(s) & ex #Braintale wearing two hats) Louis Potel (Resah) and Hicham CHEHADE (OPTACARE) for their highly complementary insights and experiences… and, of course, to the audience for actively participating in the Q&A and voting throughout the discussion !
A topic that clearly deserves further exploration: how can we shorten the time between an innovation becoming available and its actual use?
#Healthcare#Innovation#bpifrance#modération#dialogue
Julie RachlineShahrzad MoradiMaryline BROWNE-DIGUERHERDavid MarquesOlivier ChabanonLa French CareBpifrance
Grégoire Chauvière Le Drian – European Investment Bank (EIB)
Loïc Gonnet – Head of M&A at Sanofi,
Benoit Varichon – partner at ARCHIMED
Pascal Raidron – founder of EIGHT ADVISORY
Beyond the specific challenges and diverse realities of the healthcare sector, M&A activity in this field is particularly dynamic and efficient, yet grounded in practical realities: a deal requires foresight and is built on human relationships and a nuanced, local understanding—on both the buyer and seller sides. Culture and local dynamics are crucial; in healthcare, transactions cannot be conceived in isolation from their ecosystem.
It is precisely at the intersection of these factors that LallianSe supports and connects players in the sector.
Julie Rachline Shahrzad Moradi Maryline BROWNE-DIGUERHER Thierry Hassanaly Nicolas JULLIAN
A doctor doesn’t speak the same language as an entrepreneur. An entrepreneur doesn’t speak the same language as hospital management. Hospital management doesn’t speak the same language as an investor. An investor doesn’t speak the same language… you get the idea—it’s an endless loop!
And yet… talking, dialogue, and collaboration are essential for a healthcare innovation to become a reality. That is precisely where our story with the AP-HP (Assistance Publique – Hôpitaux de Paris) began in 2017, when we set up operations at the heart of the Pitié-Salpêtrière – Charles Foix University Hospitals. Over seven years of #hospitalimmersion, we gradually learned the codes, constraints, and realities—and learned to speak the languages—of the hospital ecosystem. Above all, we sparked #conversations.
These conversations paved the way for concrete initiatives: from the creation of #ASIIA (the Association of Innovative Start-ups from AP-HP) and the #BrainTale project to supporting the #OBE Foundation, as well as numerous collaborations involving doctors, paramedical staff, entrepreneurs, and other ecosystem stakeholders.
This spirit was very much present at the event “From Hospital to Start-up: Entrepreneurship for Healthcare Innovation,” held at the Sorbonne University Hospital Group (GHU). Four clinician-entrepreneurs came to share what drove them to take the leap into entrepreneurship: Pierre Mozer, Rachel Lévy, Harry Sokol, Louis PUYBASSET.
It was about translating the challenges of one “world” to make them understandable to another; enabling a clinician, an entrepreneur, an institution, or an investor to understand one another well enough to build together.
This ability to build bridges is what we have been cultivating for over a decade: creating the conditions for worlds that do not naturally speak the same language to understand each other, collaborate, and bring projects to life.
#HealthInnovation #Entrepreneurship #APHP #RoundTable #Startup

The objective? To provide a compass for navigating times of uncertainty, questioning and adaptation. Each episode draws on the experience of the healthcare ecosystem — entrepreneurs, investors and experts — to help navigate the right equation: the right dynamics, with the right people, at the right time.
A fundraising round that drags on. A capital structure that no longer fits. Growth that outpaces projections. A shareholder base no longer speaking the same language…
A failed financial roadmap is never an isolated incident; it is the symptom of a deeper misalignment between strategic vision and the interests of the various stakeholders.
Does a failed roadmap doom the company? Or can it, conversely, become a turning point?
We invite you to a discussion with Jérémy Ballet, CFO and Operating Partner (Alkyon Group), as he reflects on what causes a financial trajectory to go off track, and addresses key questions:
An open conversation about choices, mistakes, lessons learned, and what can ultimately be gained from a failure—or simply an experience.
An inspiring and interactive conversation designed for healthcare executives and managers.



The project is still looking for the right entrepreneur. A leader is looking for the right investor… We are still looking for the right person to have the #conversation that can move things forward. And what if that conversation happened at BioFIT & MedFIT ?
Partner benefit: get 20% off your full pass with code: BFMF26LallianSe1706
That’s exactly where LallianSe loves to play its role as a #HealthCatalyst: building bridges, creating connections and getting the right #conversations flowing across the ecosystem.

A few highlights in figures :
• +2 000 participants from 35+ countries
• 200 exhibitors
• +100 high-level international speakers
• 75 innovation projects selected for pitch sessions
• +4 800 meetings organized via the partnership platform
… and 5 years of partnership with LallianSe !
As a healthcare #Integrator, we’re happy to contribute to these #initiatives and foster the emergence of #collaborations and #opportunities within the ecosystem.
See you in Strasbourg on December 2nd and 3rd, 2025 !
Thanks to our partnership, you can benefit from a 20% discount on full passes, applied to the “late registration”. Register now with the code : Lallianse_0306

For the 4th consecutive year we are #partners of Eurasanté through: BioFIT Event, MedFIT Event et MEDigIT Event.
These annual meetings bring together key players, promote knowledge sharing and the emergence of innovative projects. As a #Health Integrator, we are happy to support these #initiatives!
A big thank you to the Eurasanté team, especially Célestine Fillon, and to all the participants for their commitment and trust. Together, we continue to write the future of life sciences, with ever more innovation and #success.

Bringing together exhibitors, more than 500 participants from 25 different countries, business meetings, round tables, it is the ideal environment to initiate discussions and open up perspectives. As a Health Integrator we believe that this event is an opportunity for future collaborations.

For the 3rd consecutive year we are #partner of BioFIT Event, a European event dedicated to technology transfer, collaborations between industrialists and academics and early-stage innovations.
#BioFIT is also a European marketplace for seed #investment and venture capital. In Marseille on December 12 & 13 and online on December 15, 2023.

For the 2nd year we are #partner of #MedFIT: European event dedicated to #medtech and #health in general. In Strasbourg on October 10 & 11 and online on October 17, 2023.
As a Health #Integrateur and equity story builder, this event was an #opportunity for future #collaborations.

BioFIT Event is the leading #event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. It is also the European marketplace for seed capital and venture capital investment in Life Sciences.
It is in particular with her #BrainTaleCEO‘s cap that Julie Rachline was present. Indeed, LallianSe builds, develops and manages the equity story of BrainTale, our flagship initiative since 2016 :
– Cofounding of the company with Vincent Perlbarg, Didier Cassereau, Louis Puybasset, Damien Galanaud & Velly Lionel
– Integration and reinforcement of the team,
– Accommodation in hospital coworking,
– Management of experts and entrepreneurs in residence,
– Fundraising…

You had the opportunity to meet us during the 10th edition of #BioFIT2021 and the 5th edition of #MedFIT2021 in digital format from December 7 to 9, 2021 where LallianSe was a partner.
BioFIT Event is the leading event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the European marketplace for seed and venture capital investment in Life Sciences. www.biofit-event.com
MedFIT Event is the first European convention dedicated to partnership innovation and the marketplace for early-stage innovations in the field of medical technologies, diagnostics and digital health. www.medfit-event.com
Physician, researcher, entrepreneur… and more!
7pm– Dialogue & discussion :
A physician, researcher, and entrepreneur who has also long been active in the worlds of art and creativity, Edem moves between realms often perceived as separate.
As the founder of Rumb and Polyominos and president of 49 Nord 6 Est – Frac Lorraine, his career explores the intersections of life sciences, innovation, the human body, creativity, and culture. It is a unique path that invites us to shift our perspective: what if creativity, experimentation, doubt, and even a change in viewpoint—elements essential to both research and art—could also transform the way we build, make decisions, and lead a company?
We have designed this evening to foster open, direct dialogue among peers in an intimate setting:
– What can art—and creativity in a broader sense—contribute to how we approach innovation, leadership, and business?
– How can one remain open to experimentation and doubt when, as a CEO, one must make quick decisions and rally an organization?
– Must we really choose between scientific excellence, business performance, and creative freedom?
8:30pm– The evening will continue over sociable drinks
Are you a #HealthtechCEO ? Joins us for an intellectual and collective breath, to take a step back and exchange ideas.